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Between January 2001 and December 2005, 117 patients with infective
endocarditis on native valves were operated in the active phase of the disease.
The average age of our patients was 40.32 years with a male ascendancy. The
causal heart disorder was found in 89% of the cases, dominated by rheumatoid
arthritis. The germ in cause was isolated in 52.7% of the cases. The operative
indication was hemodynamic in 60 cases, infectious in 14 cases, prosthetic
valve endocarditis with severe prosthetic dysfunction and embolic in 18 cases.
The average operating delay was of 16.38±16.88 days with regard to the
beginning of the antibiotic treatment. We realized valvular aortic replacement
at31 patients with reconstruction of the ring in ten cases, a valvular mitral
replacement at 35 patients, a mitroaortic replacement at 20 patients, a recon-
structive mitral surgery in 26 cases, and a reconstructive tricuspid surgery in
five cases. 
The early mortality was 20.5%. The follow-up was 89% with an average
recession of 3.1 years and a late mortality of 7%. The aim of this study is to
analyze the immediate and late results of the surgery of infective endocarditis
in the active phase and to bring to light the prognostic factors of mortality.
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Is redo percutaneous mitral balloon valvuloplasty indicated in
patients with mitral restenosis?
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Krichène, S Mallek, Mohamed Sahnoun, F Triki, Mourad Hentati, Samir
Kammoun
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It is unknown if patients who developed symptomatic mitral restenosis
after PMV may benefit from repeat percutaneous mitral balloon valvuloplasty
(PMV). Our purpose is to assess the immediate and long-term outcomes of
repeat PMV for post-PMV mitral restenosis.
We report the immediate outcomes and long-term clinical follow-up results
of 73 patients (mean age 29,95 years, 80,6% women) with symptomatic mitral
restenosis after prior PMV, who were treated with a repeat PMV at 51,73±29,4
months after the initial PMV. The mean follow-up period was 58, 85 months .
There was a significant increase in the mitral valve area (1,08±0,21 to
1,76±0,32; p<0,001), and decrease in the mean transmitral gradient
(15,28±6,84 to 8,67±4,07 mm Hg; p<0.001) and the mean left atrial pressure
(25,01±7,33 to 14,75±5,88 mm Hg; p<0,001). Mean pulmonary artery pres-
sure decreases significantly with redo PMV (47,5±14,73 to 34,38±9,57;
p<0,001).
The onset of new mitral regurgitation had occurred in 15 patients (21, 7%)
Successful procedural outcome was achieved in 79, 6% of patients. No patient
developed severe mitral regurgitation after redo PMV.
There were no in-hospital complications. Early symptomatic improvement
after redo PMV of 1 NYHA functional class was obtained in 96.7% of the
patients. During the follow-up period, there were no deaths, and 10 (13, 69%)
patients required mitral valve replacement.
Overall, 44 patients (60, 27%) were alive without further valvular interven-
tion at follow up after redo PVM. All of these patients were in NYHA class I
or II at follow-up. The probability of event-free survival (alive and free of
mitral valve replacement and/or NYHA class >III) at follow up was 91.2%.
By univariate analysis age, history of previous surgical commissurotomy,
pre-PMV NYHA functional class, lower echocardiographic score, post-PMV
pulmonary artery pressure and atrial fibrillation were identified as univariate
predictors of long-term event-free survival in the redo PMV group.
Repeat percutaneous mitral valvuloplasty in patients with restenosis after a
prior percutaneous valvuloplasty is feasible and can be accomplished with
acceptable morbidity and mortality. 
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tension
Bassem Jerbi (1), Leila Abid (2), Souad Mallek (2), Triki Faten (2), Hen-
tati Mourad (2), Kamoun Samir (2)
(1) Centre hospitalier de Versailles, service de cardiologie, Le Chesnay,
France - (2) CHU Hedi Chaker, service de cardiologie, Sfax, Tunisie
Introduction:
 
 The percutaneous balloon mitral valvuloplasty (PBMV)
became the procedure of choice of the mitral stenosis with favorable mor-
phology. The development of the pulmonary hypertension (PH) is a frequent
in patients with mitral stenosis. However, its influence on results of the PBMV
is unknown. 
 
Aim:
 
 To determine the impact of the PH on immediate and long term
results of the PBMV. 
 
Patients and methods:
 
 Retrospective study that spreads on 6 years (from
1996 to 2002) regrouping all patients having undergone a PBMV for the first
time. Clinics, echographic, hemodynamic data of patients have been collected.
72 patient had a systolic arterial pulmonary pressure (SPP) 60 mmHg (group
H) whereas 217 had a SPP <60 mmHg (group N). 
 
Results: 
 
Group H patients were older, had more acute pulmonary edema at
admission, an echographic score >8, tricuspid regurgitation and smaller pre
PBMV mitral surface. A bad result was noted in 11.4% in group H against
8.6% in group N (p=0, 04). Post procedural complications were similar, except
for the severe mitral regurgitation, more often frequent in the group H. During
a mean follow-up of 92 months, fifty-three patients in group H and 204
patients in group N were free of cardiac events. The NYHA class I or II were
met more in the N group. The residual systolic pulmonary pressure was higher
in H group.
 
Conclusion:
 
 The PBMV is an efficient procedure even in presence of PH
in spite of the pejorative character that it confers on the immediate and long-
term prognosis.
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Background:
 
 Although trans aortic valve implantation (TAVI) is a prom-
ising alternative solution for patients who could not undergo conventional sur-
gery, few data are available regarding post-procedure complications among
these fragile subjects
 
Objectives:
 
 We sought to evaluate the factors associated with adverse out-
come in patients with TAVI.
 
Methods:
 
 Clinical, biological and echocardiographic characteristics of the
patients were assessed before implantation.Patients were followed up to 30
days after procedure. Our main primary end-point was the composite of
death+stroke+acute pulmonary edema at day 30.
 
Results:
 
 Between November 2008 and March 2010, n=55 patients under-
went TAVI in our institution (mean age=84.4±0.7 y; 40% men; mean STS
score=25.2±1.3; 65% transfemoral). Primary endpoint occured in n=9 subjects
(n=2 deaths; n=1 stroke; n=6 pulmonary edema), who presented a longer in-
hospital stay (14.4±3.2 vs. 9.2±0.6 days, p=0.008).
Patients experiencing the primary endpoint were comparable to the others
in terms of age, gender, renal function, comorbidities, type of percutaneous
 © Elsevier Masson SAS. All rights reserved.
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approach and STS score. The pre-implantation aortic gradient was lower in
patients with adverse outcome (35.9±4.0 vs. 55.0±2.9 mmHg, p=0.007), yet
the left ventricle ejection fraction (LVEF/ 56.4±1.9 vs. 58.4± 6.0%, p=0.7) and
effective orifice area (0.43±0.03 vs. 0.37±0.02 cm2/m2, p=0.12) did not sig-
nificantly differ between the é groups. Among these patients, n=7 had
LVEF>50%. 
Receiver operating curve analysis showed a significant relationship
between aortic gradient and primary end-point (AUC= 0.82±0.07, p=0.002).
Multivariate analysis identified presence of a low trans-aortic gradient (<40
mmHg) as the sole predictor of primary endpoint (HR=9.3 [1.9-45.0],
p=0.006).
 
Conclusion:
 
 Patients with baseline low trans aortic gradient, as a result of
either altered LVEF or paradoxical low flow aortic stenosis syndrome, have a
higher incidence of major complications after TAVI and should be identified
before procedure. 
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Purpose:
 
 Implantation of an “undersized” prosthesis has been proposed as
a major cause of moderate to severe para-valvular AR after transcatheter aortic
valve implantation (TAVI). We evaluated the impact of a prospective and sys-
tematic “oversizing” implantation policy of the EDWARDS-SAPIEN pros-
thesis on para-valvular aortic regurgitation (AR) inconsecutive patients.
 
Methods:
 
 To grade AR, 2D transthoracic echocardiography was performed
before, before discharge and 1 month after the procedure. Aortic annulus
diameter was measured by TEE at baseline. The “oversizing” policy was
defined as the following: 1) Patients with an annulus > 24mm during the
screening were excluded from TAVI; 2) A 26mm prosthesis was used in all
patient with an annulus >21mm and the TA approach could be preferred when
appropriate; 3) in patients with an annulus 21mm, a 26mm prosthesis was also
used every time the predilatation with a 23mm balloon suggested that the
largest prosthesis could be accommodated.
 
Results:
 
 A 26mm prosthesis was used in 16/22 (73%) and a 23mm pros-
thesis in 6/22 (27%). "Oversizing" as estimated by the cover index (100x[pros-
thesis diameter - annulus diameter by TEE/prosthesis diameter ]) was
12.4±4.3%. 
At baseline the mean annulus diameter was 22.0±1.3 and a significant AR was
observed in 9/22 patients (41%). It was mild, moderate or severe respectively
in 5 patients (23%), 3 patients (13%) and 1 patient (5%). AT 1 month follow-
up a significant AR was observed in 5/18 patients (27%). It was mild, mod-
erate or severe respectively in 5 patients (27%), 0 patient (0%) and 0 patient
(0%) all cases. Only mild ARs appeared at 1 month in 5 out of the11 patients
with no AR at baseline.
 
Conclusion:
 
 Using a systematic "oversizing" policy resulted in no mod-
erate to severe AR after 1 month follow-up. These data provide additional sup-
port to the concept that systematic "oversizing" of the Edwards-SAPIEN valve
is an important safety measure.
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Hypoxemia due to right-to-left interatrial shunt with no pulmonary
artery hypertension. One centre experience with transcatheter closure
including 63 consecutive patients.
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Hypoxemia related to interatrial right-to-left shunt may have a significant
impact on exercise tolerance. We report here one centre experience in tran-
scatheter closure of interatrial RL shunt.  
From August 1995 to 2009, 63 consecutive patients (37 females and 26
males, mean age 54 ± 24 years), underwent transcatheter closure of interatrial
RL shunt because of cyanosis and shortness of breath at exercise. Associated
malformations were modified Fontan (n = 4), Ebstein anomaly (n = 1), RV
hypoplasia (n = 1), pectus excavatum (n = 2), aortic aneurysm (n = 1). Ten pts
had a past history of stroke. A real platypnea-orthodeoxia syndrome was
noticed in only 17 pts. The vast majority of patients had cardiac catheterization
under local anaesthesia with a sole fluoroscopic control. None of them had
pulmonary artery hypertension. Transcatheter closure was performed with a
Sideris device (n = 10), a PFO Amplatzer occluder (n = 40), an ASD
Amplatzer occluder (n = 8), a Cardioseal device (n = 3), a VSD Amplatzer
occluder (n = 2). Device implantation succeeded in all but two (1 Sideris and
1 Cardioseal device). The fluoroscopic time was 12 ± 8 minutes. 
All patients had better clinical tolerance after closure with an oxygen satu-
ration > 92 %. All underwent serial echocardiographic follow-up with bubble
study. One month after implantation, no shunt was noticed in all but 6 pts (tiny
RL shunt). In 5 of these remaining pts, the 6-month control did not see any
residual shunting. 
Transcatheter closure of interatrial RL shunt responsible of cyanosis is an
effective and a safe method. Many devices using a double disk system can be
employed and provide excellent results. The classic platypnea-orthodeoxia
syndrome is observed in < 25 % of this population.
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Background: L
 
eft atrium (LA) remodeling has a crucial adverse impact on
outcome and prognosis in mitral stenosis (MS). Few studies have reported the
effect of balloon mitral valvuloplasty (BMV) on LA volume. The aim of this
study was to assess the evolution of LA volume immediately and 1 month
after successful BMV in patients in sinus rhythm
 
.
Methods:
 
 Thirty-three consecutive patients (70% women; age 31±8 years;
range 19-45) with moderate to severe MS (mitral valve area 1.5 cm
 
2
 
) who
underwent successful BMV were included prospectively. Using two-dimen-
sional echocardiography, and according to the prolate ellipse method, LA
volume and LA volume indexed to body surface area were determined before
BMV, 24 hours and 1 month after BMV. Pulmonary artery–right ventricular
(PA-RV) gradients, reflecting pulmonary pressures, and pulmonary vascular
resistance were measured.
 
Results:
 
 Mitral valve area increased from 0.88±0.16 to 1.55±0.26 cm
 
2
 
(p<0.0001). Mean mitral valve gradient (MVG) decreased from 16±6 to 6±2
mmHg (p<0.0001) immediately after BMV. Indexed LA volume fell from
56±14 to 48±12 mL/m
 
2
 
 (p=0.0002) immediately after BMV and to 45±13 mL/
m
 
2
 
 at 1 month (p<0.0001). Only patients with a median LA volume 55 mL/m
 
2
 
before BMV had a significant reduction in LA volume (p=0.0001). Decrease
in LA volume was correlated with decreases in PA–RV peak diastolic gradient
(r=0.45, p=0.008) and MVG (r=0.35, p=0.04).
 
Conclusion:
 
 In patients with MS in sinus rhythm, successful BMV results
in an immediate decrease in LA volume. This reduction, maximal immediately
after BMV, correlates with decreases in MVG and PA–RV peak diastolic gra-
dient, and is significant only when LA volume before BMV is severely
enlarged.
